MedTrace Logo

Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes

NCT03534193 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-12-17

Study results available
· View outcomes & findings →

Summary

This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to \*standard Children's Hospital- Molly Center diabetes education in comparison to \*standard Children's Hospital- Molly Center diabetes education. (standard diabetes education consists of paper based reading material and nursing education).

Conditions

  • Type 1 Diabetes Mellitus

Interventions

OTHER

Molly Center Diabetes Care Guide (Paper-based)

Diabetes education with Registered Nurse in addition to Paper based education modules

OTHER

Tablet based interactive diabetes education modules

Molly Center Standard Diabetes Education plus access to interactive diabetes education modules through bedside tablet.

Sponsors & Collaborators

  • Verizon Foundation

    collaborator OTHER

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • Steven Ghanny, MD · Joseph M.Sanzari Children's Hospital at Hackensack University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-17
Primary Completion
2019-04-30
Completion
2025-04-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03534193 on ClinicalTrials.gov